FDA Webview
X
about-us-banner

FDA Related News

Home / Articles / FDA Related News
latest-news-card-1
Medical Devices

FloSpine 3D-Printed Interbody Cage Cleared

FDA clears a FloSpine 510(k) for its a 3D-printed titanium Ti-Largo cervical interbody cage system to support the spine after a cervical collapse or a...

latest-news-card-1
Medical Devices

Convatecs Extracellular Matrix Wound Care Cleared

FDA cleared a Convatec 510(k) for its InnovaMatrix PD particulate placental extracellular matrix medical device for wound management.

latest-news-card-1
Human Drugs

CDER 2022 Drug Safety Priorities Report Out

FDA publishes the CDER Drug Safety 2002 Priorities Report reviewing the many drug safety activities the Center undertook in 2022.

latest-news-card-1
Human Drugs

FDA, FTC Advancing Biologic Competition

CDER director Patrizia Cavazzoni describes how FDA and FTC are working collaboratively to increase competition for biologic products.

latest-news-card-1
Federal Register

Panel to Review Lynparza sNDA for Prostate Cancer

Federal Register notice: FDA announces a 4/28 Oncologic Drugs Advisory Committee meeting to review an AstraZeneca supplemental NDA for Lynparza (olapa...

latest-news-card-1

Drug, Device Recalls Shoot Up in 2022: Report

The Sedgwick 2022 recall report says both drug and medical device recall events surged higher in 2022, with drugs outpacing devices.

latest-news-card-1
Human Drugs

8 Observations in Cipla FDA-483

FDA releases the form FDA-483 with eight observations from an inspection at the Madhya, Pradesh, India-based Cipla facility that manufactures sterile ...

latest-news-card-1
Medical Devices

Many Deficiencies in Musk Neuralink Brain Chip: FDA

A Reuters investigative report relying on anonymous sources says FDA has rejected an application from Elon Musks Neuralink to open human trials of its...

latest-news-card-1
Human Drugs

Bill to Restrict REMS from Delaying Competition

A Senate bipartisan bill aims to close a loophole that pharmaceutical companies can exploit to block drug competition, including generic drugs.

Biologics

FDA, Expert Debate Bivalent Covid Vaccine Deployment

FDA commissioner Robert Califf, CBER director Peter Marks, and Childrens Hospital of Philadelphia vaccine expert Paul Offit debate in the New England ...